The Captain James A. Lovell Federal Health Care Center, opened on October 1, 2010, and is the United States' first federal health care center that partners the United States Department of Veterans Affairs and the Department of Defense into a single, fully integrated federal health care facility.

During the past decade, North Chicago VA Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Chicago VA Medical Center" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Chelsea Therapeutics" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Chicago VA Medical Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Bright Research Partners" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "North Chicago VA Medical Center" are "Heart Failure" (4 trials), "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Age Related Macular Degeneration" (1 trials), "Amputation" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "North Chicago VA Medical Center" in a lesser frequency.

Most popular intervention types in "North Chicago VA Medical Center" are "Drug" (13 trials), "Other" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Droxidopa" (2 trials), "Empagliflozin" (2 trials), "Lenalidomide" (2 trials) and "3R 3'R Zeaxanthin" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Chicago VA Medical Center" are 18 trials for "All" genders.

Currently, there are NaN active trials in "North Chicago VA Medical Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in North Chicago VA Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in North Chicago VA Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".